Research progress of lipoprotein a in cardiovascular diseases / 重庆医学
Chongqing Medicine
; (36): 3648-3652, 2023.
Article
en Zh
| WPRIM
| ID: wpr-1017424
Biblioteca responsable:
WPRO
ABSTRACT
Lipoprotein a[Lp(a)]is a risk factor for cardiovascular disease.This paper summarizes the structure,anabolism and mechanism of action of Lp(a),and the relationship between Lp(a)and cardiovascular diseases,liver and kidney diseases,diabetes mellitus and other diseases.It focuses on the traditional lipid-low-ering regimen to reduce plasma Lp(a)level and the current popular novel therapies,such as mipomersen,pel-acarsen,olpasiran,and the interfering effect of related drugs on Lp(a)level and the degree of benefit on cardi-ovascular events.How to reduce plasma Lp(a)level and improve patient prognosis will be the key to future Lp(a)related research.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chongqing Medicine
Año:
2023
Tipo del documento:
Article